Article

Schwind, Ziemer form marketing alliance

Schwind eye-tech-solutions and Ziemer Ophthalmic solutions have formed a marketing alliance to offer an integrated system featuring their lasers for refractive surgeons performing all-laser LASIK.

Kleinostheim, Germany, and Port, Switzerland—Schwind eye-tech-solutions and Ziemer Ophthalmic Systems have formed a marketing alliance to offer an integrated system featuring their lasers (Amaris excimer and Femto LDV femtosecond, respectively) for refractive surgeons performing all-laser LASIK.

“Ziemer’s femtosecond laser is an ideal complement to our product range and offers attractive added value for our existing and new customers,” said Rolf Schwind, chief executive officer of Schwind.

Ziemer Group President Frank Ziemer said, “With Schwind, we are forming an alliance with a strong and reliable partner to address additional market opportunities.”

The two companies will serve international markets through their existing distribution networks. Distribution partners jointly will offer packages to their customers.

The marketing alliance is non-exclusive. Both companies will continue to market and sell their products individually as well as jointly, and both companies remain open to collaborations with other manufacturers and providers of surgical laser systems.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.